Corcept loses patent spat against Teva, shares tumble
(Reuters) -A U.S. judge ruled in favor of Israel’s Teva
(Reuters) -A U.S. judge ruled in favor of Israel’s Teva
By Blake Brittain (Reuters) – The California Institute of Technology
By Blake Brittain WASHINGTON (Reuters) – A U.S. Patent Office
By Blake Brittain (Reuters) – The California Institute of Technology
By Hyunjoo Jin SAN FRANCISCO (Reuters) – South Korea’s Samsung
By Blake Brittain WASHINGTON (Reuters) – The U.S. Supreme Court
By Blake Brittain (Reuters) – Biotech company Alnylam Pharmaceuticals Inc
By Blake Brittain (Reuters) – The U.S. solicitor general on
By Blake Brittain (Reuters) – Genetic testing company Natera Inc
By Blake Brittain (Reuters) – Alphabet’s Google LLC won a
By Blake Brittain (Reuters) – Computer-memory company Netlist Inc convinced
By Blake Brittain (Reuters) – Amgen Inc convinced a U.S.
By Blake Brittain (Reuters) – Alphabet’s Google LLC on Tuesday
By Blake Brittain (Reuters) – Gene-sequencing giant Illumina Inc has
By Blake Brittain (Reuters) – Despite the backing of the
By Blake Brittain (Reuters) – Samsung Electronics Co failed to
Now available to lease or buy, the breakthrough system offers
(Reuters) – Pfizer /BioNTech and Moderna have been hit with
Moderna Suing Pfizer For COVID-19 Vaccine Patent Infringement Trevor Schakohl
By Ludwig Burger FRANKFURT – COVID-19 vaccine maker BioNTech said
PRINCETON, N.J., July 7, 2022 — Miami International Holdings, Inc.
PRINCETON, N.J., July 7, 2022 — Miami International Holdings, Inc.
BERLIN – A German court has put a nation-wide sales
– A Russian court on Thursday overturned a ruling that
By Blake Brittain – Meatless burger maker Impossible Foods sued